Recombinant acellular pertussis vaccines (RaPV)

Pertussis, or whooping cough, is a highly contagious bacterial infection caused by Bordetella pertussis that can be deadly in young infants and frail older people.  Pertussis is one of the least controlled vaccine preventable diseases in the world.

BioNet’s recombinant acellular pertussis vaccines are produced using genetically detoxification technology to ensure a safe but more effective vaccine.  Our recombinant pertussis vaccines have been tested in 15+ clinical trials, confirming the vaccine’s safety profile and ability to induce high and long-lasting antibody responses in both teenagers and adults, including pregnant women.